UA118305U - METHOD OF TREATMENT OF ATTRIBUTED ABORTION IN WOMEN DEPENDING ON POLYMORPHISM OF PROGESTERON RECEPTOR GENE RS590688 - Google Patents

METHOD OF TREATMENT OF ATTRIBUTED ABORTION IN WOMEN DEPENDING ON POLYMORPHISM OF PROGESTERON RECEPTOR GENE RS590688

Info

Publication number
UA118305U
UA118305U UAU201704011U UAU201704011U UA118305U UA 118305 U UA118305 U UA 118305U UA U201704011 U UAU201704011 U UA U201704011U UA U201704011 U UAU201704011 U UA U201704011U UA 118305 U UA118305 U UA 118305U
Authority
UA
Ukraine
Prior art keywords
polymorphism
abortion
receptor gene
attributed
treatment
Prior art date
Application number
UAU201704011U
Other languages
Ukrainian (uk)
Inventor
Олександр Сергійович Кривопустов
Original Assignee
Національний Медичний Університет Ім. О.О. Богомольця
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Національний Медичний Університет Ім. О.О. Богомольця filed Critical Національний Медичний Університет Ім. О.О. Богомольця
Priority to UAU201704011U priority Critical patent/UA118305U/en
Publication of UA118305U publication Critical patent/UA118305U/en

Links

Landscapes

  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Спосіб лікування загрозливого аборту у жінок залежно від поліморфізму гена рецептора прогестерону rs590688 включає призначення натурального мікронізованого прогестерону. Натуральний мікронізований прогестерон призначають в дозі 100 мг 3 рази на добу перорально при наявності у жінки гетерозиготи CG або мінорної гомозиготи GG та в дозі 200 мг 3 рази на добу перорально при наявності мажорної гомозиготи СС.A method of treating threatening abortion in women, depending on the polymorphism of the rs590688 receptor gene comprises the administration of natural micronized progesterone. Natural micronized progesterone is administered at a dose of 100 mg 3 times per day orally in the presence of female CG heterozygotes or minor GG homozygotes and at a dose of 200 mg 3 times orally in the presence of major SS homozygotes.

UAU201704011U 2017-04-24 2017-04-24 METHOD OF TREATMENT OF ATTRIBUTED ABORTION IN WOMEN DEPENDING ON POLYMORPHISM OF PROGESTERON RECEPTOR GENE RS590688 UA118305U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201704011U UA118305U (en) 2017-04-24 2017-04-24 METHOD OF TREATMENT OF ATTRIBUTED ABORTION IN WOMEN DEPENDING ON POLYMORPHISM OF PROGESTERON RECEPTOR GENE RS590688

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201704011U UA118305U (en) 2017-04-24 2017-04-24 METHOD OF TREATMENT OF ATTRIBUTED ABORTION IN WOMEN DEPENDING ON POLYMORPHISM OF PROGESTERON RECEPTOR GENE RS590688

Publications (1)

Publication Number Publication Date
UA118305U true UA118305U (en) 2017-07-25

Family

ID=59365958

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201704011U UA118305U (en) 2017-04-24 2017-04-24 METHOD OF TREATMENT OF ATTRIBUTED ABORTION IN WOMEN DEPENDING ON POLYMORPHISM OF PROGESTERON RECEPTOR GENE RS590688

Country Status (1)

Country Link
UA (1) UA118305U (en)

Similar Documents

Publication Publication Date Title
EA202091144A1 (en) GANAXOLONE FOR USE IN THE TREATMENT OF HEREDITARY EPILEPTIC DISEASES
PH12019500845A1 (en) Combinations comprising an ssao/vap-1 inhibitor and a sglt2 inhibitor, uses thereof
MX2017015574A (en) Inhibitors of bruton's tyrosine kinase.
JP2017039771A5 (en)
MX2020009773A (en) Combination therapy.
CL2018001677A1 (en) Treatment of fabry disease in patients not treated and previously treated with ert
MX2019003134A (en) Combination therapy.
MX2016011333A (en) Drug delivery systems and methods for treatment of bladder cancer with gemcitabine.
CL2021002533A1 (en) Compositions and methods for treating diseases or disorders associated with kras
MX2020001727A (en) Combination therapy.
ZA201808086B (en) Method of treating diseases
MX2021007330A (en) Therapeutic methods and compositions for treating cancer using 6,8-bis-benzylthio-octanoic acid and an autophagy inhibitor.
MX2023000187A (en) Dosing of vibegron for treatment of overactive bladder.
MX2021002322A (en) Novel methods.
ECSP17019893A (en) ANAMORELIN-BASED MEDICAL TREATMENTS
WO2017087947A3 (en) Method of treatment of follicular lymphoma with a btk inhibitor
MX2021001765A (en) Treatment of relapsed follicular lymphoma.
UA118305U (en) METHOD OF TREATMENT OF ATTRIBUTED ABORTION IN WOMEN DEPENDING ON POLYMORPHISM OF PROGESTERON RECEPTOR GENE RS590688
AU2020360413A8 (en) Methods of treating conditions related to the S1P1 receptor
UA128573U (en) METHOD OF PREVENTING PREGNANT PREGNANCY IN PREGNANT PREGNANCY WITH HYPERTENSIVE DISORDERS
AR102494A1 (en) METHODS TO TREAT EYE DISEASES
UA129564U (en) METHOD OF COMPLEX PREVENTION OF VITAMIN D DEFICIENCY AFFECTING CALCULATION, MAGNESIUM, ZINC IN PREGNANT WOMEN
Elia Various toxicities: 12 case reports
TR201719926A2 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING PHARMACEUTICALLY ACCEPTABLE LITHIUM SALTS AND VITAMIN C
UA116484U (en) METHOD OF TREATMENT OF HYPERTENSION WITH METABOLIC SYNDROME